NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Hyundai Pharm (KO: 004310)

 
004310 Technical Analysis
5
As on 13th Jun 2025 004310 STOCK Price closed @ 3485.00 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 4027.00 & Strong Sell for SHORT-TERM with Stoploss of 3918.45 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

004310STOCK Price

Open 3580.00 Change Price %
High 3580.00 1 Day -75.00 -2.11
Low 3445.00 1 Week 45.00 1.31
Close 3485.00 1 Month 50.00 1.46
Volume 216567 1 Year -550.00 -13.63
52 Week High 5820.00 | 52 Week Low 3000.00
 
KO Korea Most Active Stocks
005880 1796.00 8.91%
005880 1796.00 8.91%
152550 383.00 19.69%
152550 383.00 19.69%
096300 156.00 -6.02%
096300 156.00 -6.02%
168490 159.00 29.27%
168490 159.00 29.27%
002360 521.00 14.00%
002360 521.00 14.00%
 
KO Korea Top Gainers Stocks
119650 1581.67 244.59%
119650 1581.67 244.59%
004090 17160.00 30.00%
004090 17160.00 30.00%
168490 159.00 29.27%
168490 159.00 29.27%
117580 10170.00 24.02%
117580 10170.00 24.02%
103140 107000.00 22.15%
152550 383.00 19.69%
 
KO Korea Top Losers Stocks
009275 1800.00 -64.50%
009275 1800.00 -64.50%
010145 6580.00 -60.83%
010145 6580.00 -60.83%
001745 3600.00 -46.27%
001745 3600.00 -46.27%
016385 10450.00 -37.05%
016385 10450.00 -37.05%
002210 2780.00 -29.97%
002210 2780.00 -29.97%
 
 
004310
Daily Charts
004310
Intraday Charts
Whats New @
Bazaartrend
004310
Free Analysis
 
004310 Important Levels Intraday
RESISTANCE3745.15
RESISTANCE3661.72
RESISTANCE3610.15
RESISTANCE3558.58
SUPPORT3411.43
SUPPORT3359.86
SUPPORT3308.29
SUPPORT3224.86
 
004310 Forecast June 2025
4th UP Forecast4525.58
3rd UP Forecast4191.86
2nd UP Forecast3985.58
1st UP Forecast3779.3
1st DOWN Forecast3190.7
2nd DOWN Forecast2984.42
3rd DOWN Forecast2778.14
4th DOWN Forecast2444.42
 
004310 Weekly Forecast
4th UP Forecast3928.21
3rd UP Forecast3786.07
2nd UP Forecast3698.21
1st UP Forecast3610.35
1st DOWN Forecast3359.65
2nd DOWN Forecast3271.79
3rd DOWN Forecast3183.93
4th DOWN Forecast3041.79
 
004310 Forecast2025
4th UP Forecast10470.4
3rd UP Forecast8230.13
2nd UP Forecast6845.38
1st UP Forecast5460.63
1st DOWN Forecast1509.38
2nd DOWN Forecast124.63
3rd DOWN Forecast-1260.13
4th DOWN Forecast-3500.38
 
 
004310 Other Details
Segment EQ
Market Capital 167270400000.00
Sector Healthcare
Industry Drug Manufacturers-Specialty & Generic
Offical website >
 
004310 Address
004310
 
004310 Latest News
 
Your Comments and Response on Hyundai Pharm
 
004310 Business Profile
Hyundai Pharmaceutical Co., Ltd. manufactures and distributes pharmaceutical products, health food drinks, and medical equipment in South Korea and internationally. The company offers a range of ETC and OTC products in various therapeutic areas, including antiviral, cardiovascular, central nervous system, contraceptive, depilatory, dermatological, diagnostic, digestive system, endocrine system, ENT, hemostatic, hormone therapy, musculo-skeletal system, ophthalmic, oral disease, respiratory, urogenital system, alopecia treatment, analgesics and anti-inflammatory, anemia, antimicrobial, arthritis, constipation, disinfectant, lip care, nutrition, and wound healing. It also develops products for the treatment of type 2 diabetes, bronchitis, senile disease, and osteoporosis. The company was founded in 1965 and is headquartered in Seoul, South Korea. Address: Hyundai Pharm Building, Seoul, South Korea, 06121
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service